The Clinical Operations and Program Management team at Allogene Therapeutics oversees the execution and coordination of clinical trials for AlloCAR T™ therapies. This team ensures the clinical programs are effectively managed, regulatory standards are met, data integrity is maintained, and trial timelines are adhered to. They also manage cross-functional collaborations, overall program strategy, and alignment with corporate goals to advance the development of “off-the-shelf” allogeneic cell therapies for cancer treatment.
Chelsea Williams
Director, Clinical Operations
Danielle Dishmon
Executive Director, Global Med...
Ellen Johnson
Senior Director Operations Str...
Glenn Davis
Vice President, Portfolio And ...
Hien do
Associate Director, Drug Safet...
John Legall
Vice President Clinical Develo...
Marian Quinones.
Director CMC Lead, Portfolio A...
Mark Dimartino
Executive Director Quality Dat...
Paul Robbins
Vice President, Translational ...
Richard L.
Director, Clinical Portfolio A...
View all